SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-014000
Filing Date
2024-02-12
Accepted
2024-02-12 17:51:02
Documents
1
Period of Report
2024-02-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11006
  Complete submission text file 0000950170-24-014000.txt   13672
Mailing Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814
Business Address
Rubin Michael P. (Reporting) CIK: 0001867627 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41947 | Film No.: 24621662

Mailing Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814
Business Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814 (240) 800-1200
Northpond Ventures III, LP (Reporting) CIK: 0001972690 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41947 | Film No.: 24621663

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Issuer) CIK: 0001994702 (see all company filings)

IRS No.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814
Business Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814 240-800-1200
Northpond Ventures III GP, LLC (Reporting) CIK: 0002010695 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-41947 | Film No.: 24621664